VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2013 Labor/HHS/Education Draft, provisions related to viral hepatitis funding, BARDA funding, and funding the Strategic National Stockpile.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL WHITEFORD MACK | — |
| RICHARD WAYNE OLSON | — |
| SAMANTHA VENTIMIGLIA | — |
Health Issues HCR
Issues related to raising awareness of Hepatitis C (no specific bills); Viral Hepatitis Testing Act of 2011 (H.R. 3381, S. 1809), all provisions; Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (H.R. 2405, S. 1855), all provisions; (cont'd next page) Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012 (H.R.4156 , S.2281), all provisions; Transforming the Regulatory Environment to Accelerate Access to Treatments (S.2113), provisions; The Unlocking Lifesaving Treatments for Rare-Diseases Act (H.R.3737), all provisions; Issues related to the 2012 Prescription Drug User Fee Act Reauthorization Discussion Draft, all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL WHITEFORD MACK | — |
| RICHARD WAYNE OLSON | — |
| SAMANTHA VENTIMIGLIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.